Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies

The past decade has seen considerable excitement in the use of biological therapies in treating neoplastic disease. In particular, cancer immunotherapy and oncolytic virotherapy have emerged as two frontrunners in this regard with the first FDA approvals for agents in both categories being obtained...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastin, Donald, Walsh, Scott R., Al Saigh, Meena, Wan, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344262/
https://www.ncbi.nlm.nih.gov/pubmed/28536388
http://dx.doi.org/10.3390/biomedicines4030021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344262/
https://www.ncbi.nlm.nih.gov/pubmed/28536388
http://dx.doi.org/10.3390/biomedicines4030021

Ejemplares similares